Amedisys Reports First Quarter 2019 Financial Results and Reaffirms 2019 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Amedisys Reports First Quarter 2019 Financial Results and Reaffirms 2019 Guidance

Amedisys (AMED) PT Raised to $127 at Craig-Hallum

May 1, 2019 3:28 PM EDT

Craig-Hallum analyst Kevin Ellich raised the price target on Amedisys (NASDAQ: AMED) to $127.00 while maintaining a Hold rating following results.

Strong start to the yearmargin expansion to slow before picking back up due to CCH acquisition... More

Amedisys (AMED) Tops Q1 EPS by 21c, Offers FY Guidance

April 30, 2019 4:37 PM EDT

Amedisys (NASDAQ: AMED) reported Q1 EPS of $1.11, $0.21 better than the analyst estimate of $0.90. Revenue for the quarter came in at $467.3 million versus the consensus estimate of $460.61 million.

GUIDANCE:

Amedisys sees FY2019 EPS of $3.98-$4.09, versus the consensus of $4.02. Amedisys sees... More